Medication Assisted Treatment for Opioid Use Disorder

Medication Assisted Treatment for Opioid Use Disorder 2017-06-16T00:06:18+00:00


* Key *

You are the Key to Expanding Access to Care 

    • The Comprehensive Addiction and Recovery Act (CARA) of 2016 granted nurse practitioners and physician assistants the authority to prescribe the lifesaving medication Buprenorphine to treat Opioid Use Disorder.
    • 30 million people are without access to Medication Assisted Treatment such Buprenorphine.
    • Rural parts of the country are disproportionately affected by the provider shortage, particularly across the Midwest.
    • Reports show that physicians are shying away from Buprenorphine certification due to low reimbursement rates, strict DEA regulations, and stigma.
    • A 2012 AHRQ report identified that APRNs are mostly likely to practice in large, small and remote rural communities most affected by the shortage of waivered physician.
    • Every day patients are turned away from treatment and face long waits to see a provider risking overdose, exposure to hepatitis or even HIV.


Watch “Medication to Treat Opioid Use Disorder” 

Running time 2:25 minutes


Watch “I’m Ready to Prescribe” PowerPoint Presentation

Running time: 8:22 minutes

Notes Page-I’m Ready to Prescribe.pdf – Click to print presentation

Steps to Waiver.png

Steps to Applying for a Waiver.pdf

Review the “Medication Assisted Treatment” Infographic 

MAT picture.PNG

Medication Assisted Treatment for Opioid Use Disorder 2017 AACN-NIDA.pdfPreview the documentView in a new window

Resources and Other Training

SAMSHA Medication Pocket Cards

MAT Pocket Guide.PNG

SMA16-4892PG-Pocket Guide MAT.pdfPreview the documentView in a new window


Additional Training & Resources 

PCSSMAT (Links to an external site.)

Waiver Training Link (Links to an external site.)

Primary Care Example of Successful Implementation

Fiellin_et_al-2008-The_American_Journal_on_Addictions-Primary Care Example.pdfPreview the documentView in a new window